Division of Dermatology, Faculty of Health Sciences, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa ABSTRACT BACKGROUND: Glutathione (GSH) is the most abundant naturally occurring non-protein thiol that protects mammalian cells from oxidative stress
Tirzepatide targets both GLP-1 and GIP receptors, providing a more comprehensive approach to weight loss
Without these lifestyle changes, the weight lost is likely to return." DeWitt suggests you keep an eye on your numbers and data and create a plan that works for you
Complete List of FDA-Approved GLP-1 Medications (2026) Tirzepatide (Mounjaro/Zepbound) is a dual GIP/GLP-1 agonist technically not a pure GLP-1 drug, but clinically grouped in the same class due to mechanism overlap and similar prescribing patterns
Potential Long-Term Risks: Digestive Issues Some people experience nausea, bloating, or constipation even after long-term use